National Storage Mechanism | Additional information
RNS Number : 3391L
ConvaTec Group PLC
12 May 2022
 

ConvaTec Group Plc

 

Results of Annual General Meeting

 

 

Reading, United Kingdom (12 May 2022) - Poll Result

ConvaTec Group Plc ("ConvaTec") held its Annual General Meeting today ("AGM"). The results of the poll held in relation to the resolutions proposed at the AGM are set out below

 


For (see note 2)

Against (see note 2)

Votes Total

% of ISC Voted

Votes Witheld

Resolution

No of shares

%

No of Shares

%


1

Receive Annual Report and Accounts

      1,827,980,026

99.99%

            138,955

0.01%

      1,828,118,981

89.85%

        2,678,250

2

Approve the Directors' Remuneration Report

      1,310,074,242

72.51%

      496,566,511

27.49%

      1,806,640,753

88.80%

      24,156,478

3

Declare Final Dividend

      1,828,471,889

99.87%

         2,318,530

0.13%

      1,830,790,419

89.98%

              6,812

4

Re-elect John McAdam as a director

      1,785,547,176

97.61%

        43,742,972

2.39%

      1,829,290,148

89.91%

        1,507,083

5

Re-elect Karim Bitar as a director

      1,824,546,868

99.66%

         6,234,317

0.34%

      1,830,781,185

89.98%

            16,046

6

Re-elect Margaret Ewing director

      1,808,325,168

98.77%

        22,443,302

1.23%

      1,830,768,470

89.98%

            28,761

7

Re-elect Brian May as a director

      1,713,823,773

94.03%

      108,742,705

5.97%

      1,822,566,478

89.58%

        8,230,753

8

Re-elect Sten Scheibye as a director

      1,824,824,180

99.68%

         5,944,289

0.32%

      1,830,768,469

89.98%

            28,762

9

Re-elect Heather Mason as a director

      1,812,618,794

99.01%

        18,149,676

0.99%

      1,830,768,470

89.98%

            28,761

10

Re-elect Professor Constantin Coussios as a director

      1,811,236,685

98.93%

        19,521,954

1.07%

      1,830,758,639

89.98%

            38,592

11

Elect Jonny Mason as a director

      1,819,579,146

99.39%

        11,187,969

0.61%

      1,830,767,115

89.98%

            30,116

12

Elect Kim Lody as a director

      1,824,822,794

99.68%

         5,812,573

0.32%

      1,830,635,367

89.98%

          161,864

13

Elect Sharon O'Keefe as a director

      1,824,954,544

99.68%

         5,812,573

0.32%

      1,830,767,117

89.98%

            30,114

14

Re-appoint Deloitte LLP as auditors

      1,828,465,498

99.95%

            830,907

0.05%

      1,829,296,405

89.91%

        1,500,826

15

Authorise the Directors to agree the auditors' remuneration

      1,830,098,448

99.96%

            671,868

0.04%

      1,830,770,316

89.98%

            26,915

16

Authorise political donations and political expenditure

      1,814,389,000

99.12%

        16,165,069

0.88%

      1,830,554,069

89.97%

          241,662

17

Authorise allotment of shares

      1,737,684,352

94.92%

        93,082,507

5.08%

      1,830,766,859

89.98%

            30,372

18

Renew the Scrip Dividend Scheme.

      1,830,739,805

100.00%

              22,649

0.00%

      1,830,762,454

89.98%

            34,777

19

Disapply pre-emption rights*

      1,796,085,428

98.35%

        30,153,440

1.65%

      1,826,238,868

89.76%

        4,558,363

20

Disapply pre-emption rights in connection with an acquisition or specified capital investment*

      1,773,062,102

97.09%

        53,175,701

2.91%

      1,826,237,803

89.76%

        4,559,428

21

Authorise purchase of own shares*

      1,828,587,725

99.91%

         1,634,548

0.09%

      1,830,222,273

89.96%

          574,958

22

Call general meetings on 14 days' notice*

      1,726,127,643

94.28%

      104,652,489

5.72%

      1,830,780,132

89.98%

            17,099

 

*Special Resolution

NOTES:

1.   All resolutions were passed.

2.   Votes "For" and "Against" are expressed as a percentage of votes received.

3.   A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4.   Total number of shares in issue at close of business on 10 May 2022 was 2,034,572,935 shares.  89.88% of capital was voted.

5.   Computershare acted as scrutineer of the poll on all resolutions.

 

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the annual general meeting have been submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.                                                                                                                                                                                                         

AGM - Resolution Two

The Board notes the voting result in relation to Resolution 2 at today's Annual General Meeting. We are grateful for the feedback and indications of support received from shareholders in advance of the Meeting and will continue to engage with shareholders who were unable to support this resolution, in order to understand their views in advance of publishing an update statement within six months of today. The Board also plans to engage with shareholders later in the year on the Remuneration Policy which will be subject to approval at the 2023 AGM.

Board Changes

As previously announced, Dr Regina Benjamin did not stand for re-election at the AGM. Sharon O'Keefe has been appointed as ConvaTec's designated Non-Executive Director for workforce engagement with effect from 13 May 2022. This statement is made in accordance with Listing Rule 9.6.11.

Enquiries

Analysts and Investors

Kate Postans, Vice President, Investor Relations                        +44 (0)7826 447 807                                                             

ir@convatec.com

 

Media

Buchanan: Charles Ryland / Chris Lane                                       +44 (0)207 466 5000                                                                                                      

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

 

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

 

 

 

 

# # #

END

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUUAVRUBUVAAR